Diabetic Neuropathy
暂无分享,去创建一个
[1] P. Lozeron,et al. [Autonomic peripheral neuropathy]. , 2012, Presse medicale.
[2] E. Feldman,et al. Hyperlipidemia: a new therapeutic target for diabetic neuropathy , 2009, Journal of the peripheral nervous system : JPNS.
[3] E. Feldman,et al. Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy , 2009, Diabetes.
[4] T. Lyons,et al. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. , 2009, The Journal of clinical endocrinology and metabolism.
[5] Karen L Price,et al. Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes , 2007, Muscle & nerve.
[6] A. Vinik,et al. Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.
[7] A. Veves,et al. Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[8] A. Gordon Smith,et al. Idiopathic neuropathy, prediabetes and the metabolic syndrome. , 2006, Journal of the neurological sciences.
[9] R. Freeman,et al. The evaluation of small fiber function-autonomic and quantitative sensory testing. , 2004, Neurologic clinics.
[10] J C Arezzo,et al. Quantitative sensory testing , 2003, Neurology.
[11] R. Freeman,et al. Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy , 2003, Neurology.
[12] W. Litchy,et al. Individual attributes versus composite scores of nerve conduction abnormality: Sensitivity, reproducibility, and concordance with impairment , 2003, Muscle & nerve.
[13] F. Logerfo,et al. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. , 2001, Diabetes care.
[14] D. Armstrong,et al. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. , 2000, Diabetes care.
[15] B Stemper,et al. Quantitative thermal perception testing in adults. , 1999, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[16] V. Bril,et al. Electrophysiological monitoring in clinical trials , 1998 .
[17] R. Freeman,et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. , 1998, Diabetes.
[18] V. Bril,et al. Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group. , 1998, Muscle & nerve.
[19] V. Bril,et al. Comparison of a Neurothesiometer and Vibration in Measuring Vibration Perception Thresholds and Relationship to Nerve Conduction Studies , 1997, Diabetes Care.
[20] M. B. Brown,et al. Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial , 1996, Neurology.
[21] M. Nathan,et al. Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial , 1995, Annals of neurology.
[22] J. Giurini,et al. Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. , 1995, Diabetes research and clinical practice.
[23] A. Veves,et al. Comparison of Risk Factors for Foot Problems in Diabetic Patients Attending Teaching Hospital Outpatient Clinics in Four Different European States , 1994, Diabetic medicine : a journal of the British Diabetic Association.
[24] A. Veves,et al. Painful Neuropathy and Foot Ulceration in Diabetic Patients , 1993, Diabetes Care.
[25] David Yarnitsky,et al. Quantitative Sensory Testing , 1992, Diabetes Care.